AVITA Medical, Inc.
RCEL
$4.10
$0.194.86%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.98% | -4.30% | -12.71% | 21.21% | 66.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.98% | -4.30% | -12.71% | 21.21% | 66.73% |
| Cost of Revenue | 24.36% | 44.91% | -0.09% | 64.33% | 87.24% |
| Gross Profit | 0.30% | -11.26% | -15.17% | 14.25% | 63.50% |
| SG&A Expenses | -10.94% | -10.38% | -22.05% | -11.93% | -1.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.54% | -1.20% | -21.40% | -4.07% | 7.17% |
| Operating Income | 25.57% | -4.53% | 33.70% | 28.65% | 31.26% |
| Income Before Tax | 23.31% | -0.59% | 18.86% | 35.44% | 25.64% |
| Income Tax Expenses | -237.50% | -189.47% | 153.57% | -87.88% | -73.33% |
| Earnings from Continuing Operations | 23.44% | -0.28% | 18.62% | 35.56% | 25.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.44% | -0.28% | 18.62% | 35.56% | 25.72% |
| EBIT | 25.57% | -4.53% | 33.70% | 28.65% | 31.26% |
| EBITDA | 27.68% | -2.23% | 36.43% | 31.28% | 33.51% |
| EPS Basic | 34.19% | 13.70% | 25.54% | 37.04% | 27.47% |
| Normalized Basic EPS | 32.02% | 18.60% | 26.28% | 39.92% | 31.58% |
| EPS Diluted | 34.19% | 13.70% | 25.54% | 37.04% | 27.47% |
| Normalized Diluted EPS | 32.02% | 18.60% | 26.28% | 39.92% | 31.58% |
| Average Basic Shares Outstanding | 16.33% | 16.21% | 9.27% | 2.36% | 2.40% |
| Average Diluted Shares Outstanding | 16.33% | 16.21% | 9.27% | 2.36% | 2.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |